Net profit of Hester Biosciences declined 73.94% to Rs 1.29 crore in the quarter ended March 2025 as against Rs 4.95 crore during the previous quarter ended March 2024. Sales rose 3.37% to Rs 81.93 crore in the quarter ended March 2025 as against Rs 79.26 crore during the previous quarter ended March 2024.
For the full year,net profit rose 45.53% to Rs 27.49 crore in the year ended March 2025 as against Rs 18.89 crore during the previous year ended March 2024. Sales rose 2.15% to Rs 311.10 crore in the year ended March 2025 as against Rs 304.55 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. | |
| Sales | 81.93 | 79.26 | 3 | 311.10 | 304.55 | 2 |
| OPM % | 23.41 | 20.09 | - | 19.63 | 17.62 | - |
| PBDT | 7.92 | 13.61 | -42 | 56.37 | 49.13 | 15 |
| PBT | 3.75 | 9.87 | -62 | 39.57 | 31.95 | 24 |
| NP | 1.29 | 4.95 | -74 | 27.49 | 18.89 | 46 |
Powered by Capital Market - Live News